2/8
02:04 am
elv
Low
Report
2/7
04:53 am
elv
How this generation of Olympic women erased the idea that motherhood is the end of a gold medal dream [CNN]
Low
Report
How this generation of Olympic women erased the idea that motherhood is the end of a gold medal dream [CNN]
2/3
10:12 pm
elv
Cigna (CI) Reports Q4: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]
Low
Report
Cigna (CI) Reports Q4: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]
2/3
06:34 pm
elv
Elevance Health (NYSE:ELV) was downgraded by analysts at
Weiss Ratings from a "hold (c-)" rating to a "sell (d+)" rating.
Low
Report
Elevance Health (NYSE:ELV) was downgraded by analysts at
Weiss Ratings from a "hold (c-)" rating to a "sell (d+)" rating.
2/3
07:00 am
elv
Elevance Health (NYSE:ELV) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating. They now have a $358.00 price target on the stock.
Low
Report
Elevance Health (NYSE:ELV) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating. They now have a $358.00 price target on the stock.
2/2
07:30 pm
elv
Elevance Health: It Has Been Painful, But This Too Shall Pass [Seeking Alpha]
Low
Report
Elevance Health: It Has Been Painful, But This Too Shall Pass [Seeking Alpha]
2/2
09:38 am
elv
Elevance Health (NYSE:ELV) had its price target raised by analysts at JPMorgan Chase & Co. from $394.00 to $397.00. They now have an "overweight" rating on the stock.
Low
Report
Elevance Health (NYSE:ELV) had its price target raised by analysts at JPMorgan Chase & Co. from $394.00 to $397.00. They now have an "overweight" rating on the stock.
2/2
09:28 am
elv
Elevance Health (NYSE:ELV) had its price target lowered by analysts at Truist Financial Corporation from $400.00 to $390.00. They now have a "buy" rating on the stock.
Low
Report
Elevance Health (NYSE:ELV) had its price target lowered by analysts at Truist Financial Corporation from $400.00 to $390.00. They now have a "buy" rating on the stock.
1/31
09:33 am
elv
Elevance Health (NYSE:ELV) had its price target lowered by analysts at Jefferies Financial Group Inc. from $401.00 to $395.00. They now have a "buy" rating on the stock.
Low
Report
Elevance Health (NYSE:ELV) had its price target lowered by analysts at Jefferies Financial Group Inc. from $401.00 to $395.00. They now have a "buy" rating on the stock.
1/31
09:33 am
elv
Elevance Health (NYSE:ELV) had its price target lowered by analysts at Sanford C. Bernstein from $431.00 to $409.00. They now have an "outperform" rating on the stock.
Low
Report
Elevance Health (NYSE:ELV) had its price target lowered by analysts at Sanford C. Bernstein from $431.00 to $409.00. They now have an "outperform" rating on the stock.
1/31
08:03 am
elv
Barclays Adjusts Elevance Health (ELV) PT to $393 While Maintaining Overweight Rating [Yahoo! Finance]
Low
Report
Barclays Adjusts Elevance Health (ELV) PT to $393 While Maintaining Overweight Rating [Yahoo! Finance]
1/31
07:19 am
elv
Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.72 [Yahoo! Finance]
Low
Report
Elevance Health's (NYSE:ELV) Dividend Will Be Increased To $1.72 [Yahoo! Finance]
1/30
09:36 am
elv
Elevance Health (NYSE:ELV) had its price target raised by analysts at Leerink Partners from $350.00 to $357.00. They now have a "market perform" rating on the stock.
Low
Report
Elevance Health (NYSE:ELV) had its price target raised by analysts at Leerink Partners from $350.00 to $357.00. They now have a "market perform" rating on the stock.
1/30
08:42 am
elv
Elevance Health (NYSE:ELV) was given a new $391.00 price target on by analysts at Wells Fargo & Company.
Low
Report
Elevance Health (NYSE:ELV) was given a new $391.00 price target on by analysts at Wells Fargo & Company.
1/30
07:02 am
elv
Elevance Health (NYSE:ELV) was given a new $393.00 price target on by analysts at Barclays PLC.
Low
Report
Elevance Health (NYSE:ELV) was given a new $393.00 price target on by analysts at Barclays PLC.
1/29
12:02 pm
elv
Elevance Health (NYSE:ELV) was given a new $400.00 price target on by analysts at UBS Group AG.
Low
Report
Elevance Health (NYSE:ELV) was given a new $400.00 price target on by analysts at UBS Group AG.
1/29
10:59 am
elv
Elevance Health (NYSE:ELV) had its "hold" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
Low
Report
Elevance Health (NYSE:ELV) had its "hold" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
1/29
10:04 am
elv
Elevance Health (NYSE:ELV) was given a new $396.00 price target on by analysts at Guggenheim.
Low
Report
Elevance Health (NYSE:ELV) was given a new $396.00 price target on by analysts at Guggenheim.
1/28
07:17 pm
elv
Elevance Health Q4 Earnings Beat Estimates on Increasing Premiums [Yahoo! Finance]
Medium
Report
Elevance Health Q4 Earnings Beat Estimates on Increasing Premiums [Yahoo! Finance]
1/28
07:02 pm
elv
Elevance Health (ELV) Reports Q4 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
Low
Report
Elevance Health (ELV) Reports Q4 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
1/28
04:16 pm
elv
Elevance Health Inc (ELV) Q4 2025 Earnings Call Highlights: Strong Financial Performance Amid ... [Yahoo! Finance]
Low
Report
Elevance Health Inc (ELV) Q4 2025 Earnings Call Highlights: Strong Financial Performance Amid ... [Yahoo! Finance]
1/28
01:07 pm
elv
Elevance Health targets at least $25.50 adjusted EPS for 2026 as company signals margin recovery and portfolio repositioning [Seeking Alpha]
Low
Report
Elevance Health targets at least $25.50 adjusted EPS for 2026 as company signals margin recovery and portfolio repositioning [Seeking Alpha]
1/28
01:06 pm
elv
Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript [Seeking Alpha]
1/28
12:43 pm
elv
Stocks making the biggest moves midday: Intel, AT&T, Stride, Elevance Health, Textron & more [CNBC]
Low
Report
Stocks making the biggest moves midday: Intel, AT&T, Stride, Elevance Health, Textron & more [CNBC]
1/28
11:10 am
elv
Elevance Health Q4 Earnings Review: No Sign Of An End To The Pain [Seeking Alpha]
Low
Report
Elevance Health Q4 Earnings Review: No Sign Of An End To The Pain [Seeking Alpha]